Status:
UNKNOWN
Quantification of Drugs and Their Degradation Products
Lead Sponsor:
University of Cologne
Conditions:
Liver Insufficiency
Kidney Failure, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study includes two study parts in which blood is collected from the patients. Study part A (observational study, already received positive ethics committee vote; Our sign: 12-330): Use of blood s...
Detailed Description
For an effective pharmacotherapy in patients with different demographic characteristics (age, weight or lean body mass), there is often a lack of information on the dosage of drugs. The predictabilit...
Eligibility Criteria
Inclusion
- Both genders are included.
- Patients willing and capable to confirm written consent prior to enrolment after ample information was given are eligible for the study.
Exclusion
- In Study Part B patients with hemoglobin less 7 mg/dl or less 10 mg/dl including serious symptoms of anemia such as increased heart rate, shortness of breath, dizziness, weakness etc.
- The hemoglobin value must not be 10 days or older.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2017
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01828372
Start Date
May 1 2013
End Date
March 1 2017
Last Update
April 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacology, Cologne University Hospital
Cologne, North Rhine-Westphalia, Germany, 50937